Outcome predictors in nitric oxide treated preterm infants

Area of Science:

• Neonatal Medicine
• Pediatric Critical Care
• Respiratory Physiology

Background:

• Preterm infants often experience poor oxygenation, necessitating interventions like inhaled nitric oxide (iNO).
• Identifying factors predicting mortality in this vulnerable population is critical for improving outcomes.
• iNO is used to improve oxygenation in neonates with persistent pulmonary hypertension.

Purpose of the Study:

• To determine factors that predict death in preterm infants receiving inhaled nitric oxide for poor oxygenation.
• To analyze the association between specific clinical conditions and mortality following iNO therapy.

Main Methods:

• Retrospective analysis of 23 preterm infants treated with inhaled nitric oxide for an oxygenation index >= 15.
• Assessment of factors including air leaks and response of the oxygenation index to iNO therapy.
• Statistical analysis to identify predictors of non-survival.

Main Results:

• Fifteen out of 23 infants (65%) died during the study period.
• Non-survival was significantly associated with the presence of air leaks (12/12 infants with air leaks died, P < 0.002).
• A suboptimal initial response to iNO (change in oxygenation index < 30%) also predicted death (P < 0.05).

Conclusions:

• Air leaks are a strong predictor of mortality in preterm infants treated with iNO for poor oxygenation.
• Lack of an initial significant improvement in oxygenation index following iNO administration indicates a poor prognosis.
• These factors can aid clinicians in risk stratification and management decisions for preterm neonates receiving iNO.